Unravelling the Antibiotic Resistance: Molecular Insights and Combating Therapies
- PMID: 39964597
- DOI: 10.1007/s12010-025-05182-8
Unravelling the Antibiotic Resistance: Molecular Insights and Combating Therapies
Abstract
Antibiotics, the full-stop of invasive bacteria, have been used in clinical setups from unthreatening fever to massive challenging therapies. Constant dependency on medication upsurges the evasion of microbes from antibiotics contemporarily along with ecological footprint. Thus, the infested pathogen became resilient to antibiotics, disguised as multidrug-resistant bacteria (MDR), pandrug-resistant bacteria (PDR), and extensively drug-resistant bacteria (XDR). The etymology of genetic modifications and horizontal gene transfer played an external influence on the arising resurgence. Also, intrinsic parameters, such as antibiotic efflux pumps and the formation of biofilms, encouraged intense resistance to antibiotic drugs. This aggravated resistance in microbes builds up resistome in the environment due to selective pressure; thereby drastic devastation of people suffering from disastrous diseases is mournful. Since novelite approaches for broad-spectrum antibiotics against drug resistance microbes are grueling challenges in these crucial times. This scientific study has come up with neoteric methodologies to elude immediate consequences and health hazards. Inculcating ancestral treatment towards pharmacognosy as adjuvants to the prevailing hi-fi nanotechnology, phage and algal therapy, genome mining, and bioinformatics databases are the optimizing inventions for actual and prospective living.
Keywords: Antibiotic resistance driving mechanism; Antibiotics; Bio-nanoparticle; Pharmacognosy; Resistome.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.
References
-
- Kelly, J.B., Nolan, A.C., Zeden, M.S. (2024). How can we escape the ESKAPEs: Antimicrobial resistance mechanisms and what lies ahead? PLoS Pathog 20. https://doi.org/10.1371/journal.ppat.1012270
-
- WHO outlines 40 research priorities on antimicrobial resistance. https://www.who.int/news/item/22-06-2023-who-outlines-40-research-priori... . Accessed 4 Nov 2024
-
- Sagar, S., Kaistha, S., Das, A. J., & Kumar, R. (2019). Antibiotic resistant bacteria: A challenge to modern medicine. Springer Singapore. - DOI
-
- Shariati, A., Dadashi, M., Moghadam, M. T., et al. (2020). Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: A systematic review and meta-analysis. Science and Reports, 10, 12689. https://doi.org/10.1038/s41598-020-69058-z - DOI
-
- Jian, Z., Zeng, L., Xu, T., et al. (2021). Antibiotic resistance genes in bacteria: Occurrence, spread, and control. Journal of Basic Microbiology, 61, 1049–1070. https://doi.org/10.1002/jobm.202100201 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
